{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:19:16Z","timestamp":1788434356675,"version":"build-2803163510"},"reference-count":102,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv. Respir. Med.","ARM"],"abstract":"<jats:p>Introduction: COPD-OSA overlap syndrome (OVS) is defined by the coexistence of chronic obstructive pulmonary disease and obstructive sleep apnea syndrome in the same patient; it affects 28.3% of patients evaluated for either condition and is associated with significantly higher mortality compared to either pathology in isolation. Current therapeutic approaches, involving PAP therapy and bronchodilation, treat this syndrome as a homogeneous entity and ignore the biological heterogeneity of this patient population. Objectives: This review proposes a systematic framework for the endotypic classification of biological interactions between COPD and OSA, integrating current literature on the pathophysiological mechanisms underlying the OVS, clinically accessible biomarkers, and emerging therapies. Methods: A narrative review based on available literature, focusing on studies published between 2010 and 2026 identified via searches in PubMed, PMC, and Dove Medical Press using the terms: COPD-OSA overlap syndrome, endotype, precision medicine, phenotype, biomarker, dupilumab, and incretin-based therapies. Results: Four clinical phenotypes (obese-metabolic, emphysematous, bronchitic-hypoxemic, and hypercapnic) and three molecular endotypes (Th2\/eosinophilic, neutrophilic\/oxidative, and metabolic-adipokine) are proposed, each with distinct pathophysiological mechanisms and specific therapeutic implications. The interaction between the two conditions generates a unique, pronounced hypoxemic profile. We propose the \u201cdouble-hit hypoxemia\u201d model as a conceptual framework characterized by amplified systemic inflammation and increased cardiovascular risk compared to either pathology in isolation. This proposed model has not yet been prospectively validated. Dupilumab (approved for an inflammatory phenotype in COPD patients characterized by eosinophil counts \u2265 300 cells\/\u03bcL) represents a promising option, though currently unsupported in the OVS population, that could nonetheless be relevant to the Th2\/eosinophilic endotype of this syndrome and tirzepatide (which reduced the AHI by up to 23.8 events\/hour versus placebo in the SURMOUNT-OSA trial, conducted in patients with obesity and moderate-to-severe OSA, rather than in patients with confirmed OVS) could represent a promising therapy for the metabolic-adipokine endotype of obese patients with OVS. A minimal biomarker panel, comprising blood eosinophils, FeNO, daytime PaCO2, BMI, and T90, allows for a practical approach to identifying the dominant endotype. Conclusions: Endotyping of OVS may provide a framework for moving beyond a uniform therapeutic approach toward more individualized management based on the dominant underlying biological mechanism. Randomized clinical trials focusing on endotypic stratification and OVS cohorts remain research priorities.<\/jats:p>","DOI":"10.3390\/arm94050063","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:36Z","timestamp":1788256116000},"page":"63","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision Medicine in Overlap Syndrome (COPD\u2013Obstructive Sleep Apnea): From Phenotypes and Endotypes to Treatable Traits"],"prefix":"10.3390","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1203-363X","authenticated-orcid":false,"given":"Carina Adina","family":"Afloarei","sequence":"first","affiliation":[{"name":"Clinical Hospital of Pulmonary Diseases Iasi, 700116 Iasi, Romania"},{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5907-1876","authenticated-orcid":false,"given":"Andreea","family":"Zabara Antal","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Pulmonary Diseases Iasi, 700116 Iasi, Romania"},{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2054-3841","authenticated-orcid":false,"given":"David","family":"Toma","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Pulmonary Diseases Iasi, 700116 Iasi, Romania"},{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9991-4228","authenticated-orcid":false,"given":"Adriana Loredana","family":"Pintilie","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7057-6573","authenticated-orcid":false,"given":"Georgiana","family":"Pitusac","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Pulmonary Diseases Iasi, 700116 Iasi, Romania"},{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1947-4373","authenticated-orcid":false,"given":"Raluca","family":"Tiron","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Pulmonary Diseases Iasi, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4560-1102","authenticated-orcid":false,"given":"Tudor","family":"Birladeanu","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Pulmonary Diseases Iasi, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6709-5856","authenticated-orcid":false,"given":"Teodor","family":"Zaharia","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Pulmonary Diseases Iasi, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-0350","authenticated-orcid":false,"given":"Radu","family":"Crisan Dabija","sequence":"additional","affiliation":[{"name":"Clinical Hospital of Pulmonary Diseases Iasi, 700116 Iasi, Romania"},{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700116 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1164\/rccm.202204-0671PP","article-title":"Definition and nomenclature of Chronic Obstructive Pulmonary Disease: Time for its revision","volume":"206","author":"Celli","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2147\/COPD.S234942","article-title":"Economic burden of Chronic Obstructive Pulmonary Disease (COPD): A systematic literature review","volume":"15","author":"Iheanacho","year":"2020","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","article-title":"Global Burden of Chronic Obstructive Pulmonary Disease Through 2050","volume":"6","author":"Boers","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_4","unstructured":"Slowik, J.M., Sankari, A., and Collen, J.F. (2025). Obstructive Sleep Apnea. StatPearls, StatPearls Publishing."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00408-018-00193-1","article-title":"Predictors of Continuous Positive Airway Pressure Adherence in Patients with Obstructive Sleep Apnea","volume":"197","author":"Mehrtash","year":"2019","journal-title":"Lung"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.otorri.2018.06.008","article-title":"Clinical Practice Guideline recommendations on examination of the upper airway for adults with suspected obstructive sleep apnoea-hypopnoea syndrome. Recomendaciones de la Gu\u00eda de Pr\u00e1ctica Cl\u00ednica de la exploraci\u00f3n de la v\u00eda a\u00e9rea superior para pacientes adultos con sospecha de s\u00edndrome de apnea-hipoapnea obstructiva del sue\u00f1o (versi\u00f3n reducida)","volume":"70","author":"Esteller","year":"2019","journal-title":"Acta Otorrinolaringol. Esp."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/obr.12824","article-title":"Weight loss and lifestyle interventions for obstructive sleep apnoea in adults: Systematic review and meta-analysis","volume":"20","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"106766","DOI":"10.1016\/j.sleep.2025.106766","article-title":"Global prevalence of COPD\u2013OSA overlap syndrome: A systematic review and meta-analysis","volume":"135","author":"Li","year":"2025","journal-title":"Sleep Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.200912-1869OC","article-title":"Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: The overlap syndrome","volume":"182","author":"Marin","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1513\/AnnalsATS.202506-617ED","article-title":"The Overlap Syndrome Paradox: Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Care Doesn\u2019t Overlap","volume":"22","author":"Raphelson","year":"2025","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"560579","DOI":"10.2147\/NSS.S560579","article-title":"Diagnosis and Management of Overlap Syndrome (COPD-OSA): Evidence, Challenges and Prospects","volume":"18","author":"Wei","year":"2026","journal-title":"Nat. Sci. Sleep"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.5664\/jcsm.8466","article-title":"The risk of cardiovascular and cerebrovascular disease in overlap syndrome: A meta-analysis","volume":"16","author":"Xu","year":"2020","journal-title":"J. Clin. Sleep Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17476348.2024.2384036","article-title":"Chronic obstructive pulmonary disease and obstructive sleep apnea overlap: Who to treat and how?","volume":"18","author":"Sunwoo","year":"2024","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12931-025-03356-w","article-title":"Toward precision medicine in COPD: Phenotypes, endotypes, biomarkers, and treatable traits","volume":"26","author":"Xie","year":"2025","journal-title":"Respir. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.resp.2012.09.013","article-title":"The effect of lung stretch during sleep on airway mechanics in overweight and obese asthma","volume":"185","author":"Campana","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_17","first-page":"50","article-title":"Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis","volume":"59","author":"Kiely","year":"2004","journal-title":"Thorax"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2500\/aap.2008.29.3097","article-title":"The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence","volume":"29","author":"Santos","year":"2008","journal-title":"Allergy Asthma Proc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/thx.2005.052084","article-title":"Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea","volume":"61","author":"Heinzer","year":"2006","journal-title":"Thorax"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/japplphysiol.00455.2014","article-title":"The effect of increased lung volume in chronic obstructive pulmonary disease on upper airway obstruction during sleep","volume":"119","author":"Biselli","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1152\/japplphysiol.00919.2009","article-title":"Obesity and upper airway control during sleep","volume":"108","author":"Schwartz","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1513\/AnnalsATS.201809-628ED","article-title":"Does Associated Chronic Obstructive Pulmonary Disease Increase Morbidity and Mortality in Obstructive Sleep Apnea?","volume":"16","author":"McNicholas","year":"2019","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"190064","DOI":"10.1183\/16000617.0064-2019","article-title":"Sleep in chronic respiratory disease: COPD and hypoventilation disorders","volume":"28","author":"McNicholas","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_24","first-page":"909","article-title":"Control of breathing during sleep","volume":"118","author":"Phillipson","year":"1978","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1152\/jappl.1981.51.3.557","article-title":"Changes in ventilation and chest wall mechanics during sleep in normal adolescents","volume":"51","author":"Tabachnik","year":"1981","journal-title":"J. Appl. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/thx.40.5.364","article-title":"Changes in ventilation and its components in normal subjects during sleep","volume":"40","author":"Stradling","year":"1985","journal-title":"Thorax"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-94-007-4584-1_46","article-title":"Role of central\/peripheral chemoreceptors and their interdependence in the pathophysiology of sleep apnea","volume":"Volume 758","author":"Dempsey","year":"2012","journal-title":"Proceedings of the Arterial Chemoreception"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3949\/ccjm.83a.14104","article-title":"The intersection of obstructive lung disease and sleep apnea","volume":"83","author":"Khatri","year":"2016","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_29","first-page":"5574","article-title":"Sleep Apnea & Chronic Obstructive Pulmonary Disease: Overlap Syndrome Dynamics in Patients from an Epidemiological Study","volume":"Volume 2021","author":"Glos","year":"2021","journal-title":"Proceedings of the 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC)"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1513\/AnnalsATS.201412-551OC","article-title":"Prevalence of Sleep-disordered Breathing in Obese Patients with Chronic Hypoxemia. A Cross-Sectional Study","volume":"12","author":"Povitz","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2002-23151","article-title":"Hypercapnia in overlap syndrome: Possible determinant factors","volume":"6","author":"Resta","year":"2002","journal-title":"Sleep Breath."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1164\/rccm.200903-0347PP","article-title":"Chronic obstructive pulmonary disease and obstructive sleep apnea: Overlaps in pathophysiology, systemic inflammation, and cardiovascular disease","volume":"180","author":"McNicholas","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/rccm.200608-1190PP","article-title":"Cardiovascular morbidity in obstructive sleep apnea: Oxidative stress, inflammation, and much more","volume":"177","author":"Gozal","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"MacNee, W. (2001). Oxidants\/Antioxidants and Chronic Obstructive Pulmonary Disease: Pathogenesis to Therapy, John Wiley and Sons. Novartis Foundation Symposia.","DOI":"10.1002\/0470868678.ch11"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S4253","DOI":"10.21037\/jtd.2018.10.117","article-title":"Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease","volume":"10","author":"McNicholas","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tang, M., Wang, Y., Wang, M., Tong, R., and Shi, T. (2021). Risk for Cardiovascular Disease and One-Year Mortality in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.767982"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Tang, M., Long, Y., Liu, S., Yue, X., and Shi, T. (2021). Prevalence of Cardiovascular Events and Their Risk Factors in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Overlap Syndrome. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.694806"},{"key":"ref_38","first-page":"129","article-title":"Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: A retrospective cohort study","volume":"10","author":"Ganga","year":"2013","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.chest.2017.04.160","article-title":"COPD-OSA Overlap Syndrome: Evolving Evidence Regarding Epidemiology, Clinical Consequences, and Management","volume":"152","author":"McNicholas","year":"2017","journal-title":"Chest"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Rezaie, L., Maazinezhad, S., Fogelberg, D.J., Khazaie, H., Sadeghi-Bahmani, D., and Brand, S. (2021). Compared to Individuals with Mild to Moderate Obstructive Sleep Apnea (OSA), Individuals with Severe OSA Had Higher BMI and Respiratory-Disturbance Scores. Life, 11.","DOI":"10.3390\/life11050368"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s11325-020-02044-x","article-title":"A pilot study in men to show the effects of postural fluid shifts on the severity of obstructive sleep apnea","volume":"24","author":"Wang","year":"2020","journal-title":"Sleep Breath"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2215\/CJN.08760914","article-title":"Obstructive Sleep Apnea Severity and Overnight Body Fluid Shift before and after Hemodialysis","volume":"10","author":"Ogna","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"107516","DOI":"10.1016\/j.cct.2024.107516","article-title":"Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT\u2014OSA phase 3 trial","volume":"141","author":"Malhotra","year":"2024","journal-title":"Contemp. Clin. Trials"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1152\/japplphysiol.00755.2009","article-title":"The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility","volume":"108","author":"Owens","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1513\/AnnalsATS.201511-765OC","article-title":"Effect of Emphysema Severity on the Apnea-Hypopnea Index in Smokers with Obstructive Sleep Apnea","volume":"13","author":"Krachman","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"103315","DOI":"10.1016\/j.resp.2019.103315","article-title":"Lung air trapping lowers respiratory arousal threshold and contributes to sleep apnea pathogenesis in COPD patients with overlap syndrome","volume":"271","author":"Messineo","year":"2020","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary","volume":"207","author":"Celli","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"zsab030","DOI":"10.1093\/sleep\/zsab030","article-title":"Metrics of sleep apnea severity: Beyond the apnea-hypopnea index","volume":"44","author":"Malhotra","year":"2021","journal-title":"Sleep"},{"key":"ref_50","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (2025). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Global Initiative for Chronic Obstructive Lung Disease."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5664\/jcsm.7574","article-title":"Poor Outcomes Among Patients with Chronic Obstructive Pulmonary Disease with Higher Risk for Undiagnosed Obstructive Sleep Apnea in the LOTT Cohort","volume":"15","author":"Donovan","year":"2019","journal-title":"J. Clin. Sleep Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2002258","DOI":"10.1183\/13993003.02258-2020","article-title":"Sleep-related breathing disorders and pulmonary hypertension","volume":"57","author":"Adir","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"106014","DOI":"10.1016\/j.rmed.2020.106014","article-title":"Medication of comorbidities in females with sleep-disordered breathing during long-term CPAP therapy","volume":"169","author":"Aro","year":"2020","journal-title":"Respir. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000235619","article-title":"Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease","volume":"79","author":"Ryan","year":"2010","journal-title":"Respiration"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1183\/09031936.04.00085804","article-title":"Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD","volume":"23","author":"McNicholas","year":"2004","journal-title":"Eur. Respir. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1164\/rccm.201712-2510ST","article-title":"Research Priorities in Pathophysiology for Sleep-disordered Breathing in Patients with Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Research Statement","volume":"197","author":"Malhotra","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Voulgaris, A., Archontogeorgis, K., Chadia, K., Siopi, D., Nena, E., and Steiropoulos, P. (2024). Differences in Anthropometric, Sleep and Respiratory Characteristics between Hypercapnic and Normocapnic Patients with COPD-OSA Overlap Syndrome. J. Pers. Med., 14.","DOI":"10.3390\/jpm14060600"},{"key":"ref_59","first-page":"383","article-title":"Respiratory responses to CO2 stimulation in hypercapnic patients with obstructive sleep apnea syndrome","volume":"74","author":"Franczuk","year":"2006","journal-title":"Pneumonol. Alergol. Pol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.resp.2013.07.010","article-title":"Control of ventilation in COPD and lung injury","volume":"189","author":"Jacono","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1183\/13993003\/erj.8.4.542","article-title":"Control of breathing in obstructive sleep apnoea and in patients with the overlap syndrome","volume":"8","author":"Radwan","year":"1995","journal-title":"Eur. Respir. J."},{"key":"ref_62","first-page":"493","article-title":"Sleep-related disorders and chronic obstructive pulmonary disease","volume":"4","author":"Brown","year":"1998","journal-title":"Respir. Care Clin. N. Am."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1513\/pats.200706-077MG","article-title":"Overlap syndrome: Obstructive sleep apnea in patients with chronic obstructive pulmonary disease","volume":"5","author":"Weitzenblum","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.5665\/sleep.4808","article-title":"The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study","volume":"38","author":"Chen","year":"2015","journal-title":"Sleep"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4187\/respcare.10551333","article-title":"Sleep-disordered breathing and COPD: The overlap syndrome","volume":"55","author":"Owens","year":"2010","journal-title":"Respir. Care"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1378\/chest.89.1.30","article-title":"Acute oxygen in patients with sleep apnea and COPD","volume":"89","author":"Alford","year":"1986","journal-title":"Chest"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","article-title":"Thymic stromal lymphopoietin: Its role and potential as a therapeutic target in asthma","volume":"24","author":"Gauvreau","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Gu, S., Wang, R., Zhang, W., Wen, C., Chen, C., Liu, S., Lei, Q., Zhang, P., and Zeng, S. (2024). The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1436437"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1165\/rcmb.4838","article-title":"Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9","volume":"27","author":"Whittaker","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2102288","DOI":"10.1183\/13993003.02288-2021","article-title":"T2-high asthma phenotypes across lifespan","volume":"60","author":"Maison","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/thoraxjnl-2020-215167","article-title":"Eosinophilic inflammation in COPD: From an inflammatory marker to a treatable trait","volume":"76","author":"David","year":"2021","journal-title":"Thorax"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/all.14151","article-title":"Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation","volume":"75","author":"Allinne","year":"2020","journal-title":"Allergy"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1744666X.2017.1298443","article-title":"Commonality of the IL-4\/IL-13 pathway in atopic diseases","volume":"13","author":"Gandhi","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1113\/JP273312","article-title":"Adipose tissue inflammation by intermittent hypoxia: Mechanistic link between obstructive sleep apnoea and metabolic dysfunction","volume":"595","author":"Ryan","year":"2017","journal-title":"J. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","article-title":"Inflammatory endotypes in COPD","volume":"74","author":"Barnes","year":"2019","journal-title":"Allergy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.5664\/jcsm.10600","article-title":"Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease\/OSA overlap syndrome","volume":"19","author":"Gu","year":"2023","journal-title":"J. Clin. Sleep Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/slp2.15","article-title":"Prognosis of OSA-COPD overlap syndrome: A matter of concern","volume":"2","author":"Wu","year":"2025","journal-title":"Sleep Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1089\/ars.2019.7807","article-title":"Anti-allergic and anti-inflammatory effects and molecular mechanisms of thioredoxin on respiratory system diseases","volume":"32","author":"Zhou","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1113\/jphysiol.2013.251470","article-title":"Oxygen sensing and hypoxia signalling pathways in animals: The implications of physiology for cancer","volume":"591","author":"Ratcliffe","year":"2013","journal-title":"J. Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-022-01080-1","article-title":"Hypoxia signaling in human health and diseases: Implications and prospects for therapeutics","volume":"7","author":"Luo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/pr.2012.73","article-title":"Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males","volume":"72","author":"Lesser","year":"2012","journal-title":"Pediatr. Res."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Kim, J.E., Kim, J.S., Jo, M.J., Cho, E., Ahn, S.-Y., Kwon, Y.-J., and Ko, G.-J. (2022). The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome. Molecules, 27.","DOI":"10.3390\/molecules27020334"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/thorax.57.1.75","article-title":"Association of serum leptin with hypoventilation in human obesity","volume":"57","author":"Phipps","year":"2002","journal-title":"Thorax"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Begum, M., Choubey, M., Tirumalasetty, M.B., Arbee, S., Mohib, M.M., Wahiduzzaman, M., Mamun, M.A., Uddin, M.B., and Mohiuddin, M.S. (2023). Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications. Life, 13.","DOI":"10.20944\/preprints202310.0782.v1"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Nigro, E., Mosella, M., Daniele, A., Mallardo, M., Accardo, M., Bianco, A., Perrotta, F., and Scial\u00f2, F. (2023). Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis. Life, 13.","DOI":"10.3390\/life13020444"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Qin, Y., Aju, A., Wan, Y., Song, M., Hao, X., Li, J., and Shi, X. (2025). Clinical characteristics and risk factor analysis of overlapping syndromes of COPD-OSA with metabolic syndrome in middle-to-high altitude areas. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1737539"},{"key":"ref_88","first-page":"563981","article-title":"Association of FeNO Decline Rate with Symptom Improvement in COPD: A Real-World Observational Study","volume":"21","author":"Li","year":"2026","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.17219\/acem\/75904","article-title":"The peripheral neutrophils in subjects with COPD-OSA overlap syndrome and severe comorbidities: A feasible inflammatory biomarker?","volume":"27","author":"Macrea","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"13291335","DOI":"10.1007\/s11325-024-03013-4","article-title":"The role of neutrophil to lymphocyte ratio in patients with COPD-OSA overlap syndrome","volume":"28","author":"Yang","year":"2024","journal-title":"Sleep Breath."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3946320231216321","DOI":"10.1177\/03946320231216321","article-title":"Monocyte to eosinophil ratio as a diagnostic biomarker for overlap syndrome and predictor of disease exacerbation","volume":"37","author":"Ali","year":"2023","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"14799731241236492","DOI":"10.1177\/14799731241236492","article-title":"Evaluation of nocturnal apnea and airflow limitation as indicators for cognitive dysfunction in patients with chronic obstructive pulmonary disease\/obstructive sleep apnea hypopnea syndrome overlap syndrome","volume":"21","author":"Zhu","year":"2024","journal-title":"Chronic Respir. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.5664\/jcsm.8682","article-title":"Patients with obstructive sleep apnea present with chronic upregulation of serum HIF-1\u03b1 protein","volume":"16","author":"Gabryelska","year":"2020","journal-title":"J. Clin. Sleep Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/crj.13253","article-title":"Metabolic syndrome prevalence in patients with obstructive sleep apnea syndrome and chronic obstructive pulmonary disease: Relationship with systemic inflammation","volume":"14","author":"Zhou","year":"2020","journal-title":"Clin. Respir. J."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Czerwaty, K., D\u017caman, K., Sobczyk, K.M., and Sikorska, K.I. (2022). The Overlap Syndrome of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease: A Systematic Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010016"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Voulgaris, A., Archontogeorgis, K., Apessos, I., Paxinou, N., Nena, E., and Steiropoulos, P. (2023). Is COPD the Determinant Factor for Myocardial Injury and Cardiac Wall Stress in OSA Patients?. Medicina, 59.","DOI":"10.3390\/medicina59101759"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"108777","DOI":"10.1016\/j.rmed.2026.108777","article-title":"COPD-sleep-disordered breathing overlap and vascular risk markers in non-obese adults: The Nagahama study","volume":"255","author":"Nagasaki","year":"2026","journal-title":"Respir. Med."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Landete, P., Fern\u00e1ndez-Garc\u00eda, C.E., Mu\u00f1oz, J.M., Friera, A., Ancochea, J., Gonz\u00e1lez-Rodr\u00edguez, \u00c1., and Garc\u00eda-Monz\u00f3n, C. (2023). Sleep apnea-COPD overlap syndrome is associated with larger left carotid atherosclerotic plaques. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1104377"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zabara-Antal, A., Crisan-Dabija, R., Arcana, R.I., Melinte, O.E., Pintilie, A.-L., Grosu-Creanga, I.A., Zabara, M.L., and Trofor, A. (2025). Heart Rate Variability (HRV) in Patients with Sleep Apnea and COPD: A Comprehensive Analysis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14134630"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1096\/fba.2021-00024","article-title":"A review of therapies for the overlap syndrome of obstructive sleep apnea and chronic obstructive pulmonary disease","volume":"3","author":"Suri","year":"2021","journal-title":"FASEB Bioadv."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1164\/rccm.202109-2035OC","article-title":"Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease","volume":"206","author":"Sterling","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N. Engl. J. Med."}],"container-title":["Advances in Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2543-6031\/94\/5\/63\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:48:35Z","timestamp":1788432515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2543-6031\/94\/5\/63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":102,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["arm94050063"],"URL":"https:\/\/doi.org\/10.3390\/arm94050063","relation":{},"ISSN":["2543-6031"],"issn-type":[{"value":"2543-6031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}